Short interest in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) increased by 7.8% in December.
The number of short positions in CymaBay Therapeutics, Inc. saw a sizeable increase during December compared to the previous month ...
Tag: CBAY, Analyst Rating
Short interest in CymaBay Therapeutics, Inc. (NASDAQ:CBAY) increased by 7.8% in December.
The number of short positions in CymaBay Therapeutics, Inc. saw a sizeable increase during December compared to the previous month ...
Update on Short Interest in CymaBay Therapeutics, Inc. (NASDAQ:CBAY)
The number of short positions held in CymaBay Therapeutics, Inc. (NASDAQ: CBAY) saw a significant increase during December. As a ...
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) to Report ($1.19) Earnings Per Share in FY2022 B. Riley Predictions
CymaBay Therapeutics, Inc. is an organization (NASDAQ: CBAY). B. Riley increased their projections for CymaBay Therapeutics' earnings per share (EPS) ...
CymaBay Therapeutics, Inc. (NASDAQ:CBAY) Short Interest Update
CymaBay Therapeutics, Inc. (NASDAQ: CBAY) substantially increased the number of short positions taken during November. As of November 15th, the ...
Analysts at Cantor Fitzgerald raise their earnings forecasts for CymaBay Therapeutics, Inc.
Cullinan Oncology, Inc. (CGEM) is a company that specializes in the treatment of cancer. HC Wainwright increased their forecasts for ...
